Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Development and Validation of a Head and Neck Cancer Risk Prediction Model

Principal Investigator
Name
John Cramer
Degrees
M.D.
Institution
Karmanos Cancer Institute
Position Title
Assistant Professor
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-760
Initial CDAS Request Approval
Apr 5, 2021
Title
Development and Validation of a Head and Neck Cancer Risk Prediction Model
Summary
The Kerala Oral Cancer Screening Trial, the only randomized trial of screening for oral cavity cancer, found that screening for oral cancer reduced mortality by 27%. However, the incidence of oral cavity cancer is considerably lower in the United States than in India where the trial was conducted. Due partly to differences in the prevalence of oral cancer, the U.S. Preventive Services Taskforce (USPST) currently does not recommend any screening for oral cavity or other head and neck cancer. One major limitation preventing the USPST from recommending screening for oral cavity or other types of head and neck cancer is an unclear delineation of high-risk status. Identification of high-risk individuals (based on heavy cigarette smoking, tobacco chewing or alcohol use) may allow screening interventions to be targeted to the subset of the US population at greatest risk of head and neck cancer.
Aims

Our central hypothesis is that we will be able to identify a risk model that predicts development of oral cavity or head and neck cancer using age, race, sex, BMI, education, family history, cigarette smoking, tobacco chewing and alcohol consumption. The proposed study will provide a foundation to test this hypothesis by pursuing the following specific aims:

AIM 1: Our primary aim is to identify a risk model that predicts the incidence of oral cancer
AIM 2: Our secondary aim is to identify a risk model that predicts the incidence of head and neck cancer (oral cavity/oropharynx/larynx/hypopharynx).

Collaborators

Missako Nagasaka - Karmanos Cancer Institute, Detroit, Michigan
Amar Sukari - Karmanos Cancer Institute, Detroit, Michigan